TDRKH and breast cancer: Next, we silenced TDRKH-AS1 expression in MCF-7 and MDA-MB-231 cells using three different siRNAs specifically targeting TDRKH-AS1 (si-TDRKH-AS1#1, #2, #3) to determine the role of TDRKH-AS1 in BC progression.